Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07818564) titled 'Pilot Study on the Effects of Psilocybin on Belief Updating and Insight Formation' on Sept. 8.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Basic Science. Masking: Triple (Participant, Investigator, Outcomes Assessor).
Primary Sponsor: Brown University
Condition:
Phase I
Intervention:
Drug: Psilocybin (Usona Institute)
Recruitment Status: Not recruiting
Phase: Phase 1
Date of First Enrollment: November 2026
Target Sample Size: 24
Countries of Recruitment:
United States
To know more, visit https://clinicaltrials.gov/study/NC...